Barrie Kellam - Search Results

Year	Number of Results
2003	3
2004	2
2005	3
2007	2
2010	1
2011	3
2012	2
2013	4
2014	6
2015	4
2016	3
2017	4
2018	8
2019	6
2020	8
2021	5
2022	2

1

Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists.

Gillis A, Gondin AB, Kliewer A, Sanchez J, Lim HD, Alamein C, Manandhar P, Santiago M, Fritzwanker S, Schmiedel F, Katte TA, Reekie T, Grimsey NL, Kassiou M, Kellam B, Krasel C, Halls ML, Connor M, Lane JR, Schulz S, Christie MJ, Canals M. Gillis A, et al. Among authors: kellam b. Sci Signal. 2020 Mar 31;13(625):eaaz3140. doi: 10.1126/scisignal.aaz3140. Sci Signal. 2020. PMID: 32234959

2

Fluorophore-tagged GPCR ligands.

Middleton RJ, Kellam B. Middleton RJ, et al. Among authors: kellam b. Curr Opin Chem Biol. 2005 Oct;9(5):517-25. doi: 10.1016/j.cbpa.2005.08.016. Curr Opin Chem Biol. 2005. PMID: 16125436 Review.

3

Modulators of CXCR4 and CXCR7/ACKR3 Function.

Adlere I, Caspar B, Arimont M, Dekkers S, Visser K, Stuijt J, de Graaf C, Stocks M, Kellam B, Briddon S, Wijtmans M, de Esch I, Hill S, Leurs R. Adlere I, et al. Among authors: kellam b. Mol Pharmacol. 2019 Dec;96(6):737-752. doi: 10.1124/mol.119.117663. Epub 2019 Sep 23. Mol Pharmacol. 2019. PMID: 31548340 Review.

4

Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2.

Damaskinaki FN, Moran LA, Garcia A, Kellam B, Watson SP. Damaskinaki FN, et al. Among authors: kellam b. Platelets. 2021 Aug 18;32(6):744-752. doi: 10.1080/09537104.2020.1863939. Epub 2021 Jan 7. Platelets. 2021. PMID: 33406951 Review.

5

Novel selective β₁-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease.

Baker JG, Gardiner SM, Woolard J, Fromont C, Jadhav GP, Mistry SN, Thompson KSJ, Kellam B, Hill SJ, Fischer PM. Baker JG, et al. Among authors: kellam b. FASEB J. 2017 Jul;31(7):3150-3166. doi: 10.1096/fj.201601305R. Epub 2017 Apr 11. FASEB J. 2017. PMID: 28400472 Free PMC article.

6

Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies.

Soave M, Heukers R, Kellam B, Woolard J, Smit MJ, Briddon SJ, Hill SJ. Soave M, et al. Among authors: kellam b. Cell Chem Biol. 2020 Oct 15;27(10):1250-1261.e5. doi: 10.1016/j.chembiol.2020.06.006. Epub 2020 Jun 30. Cell Chem Biol. 2020. PMID: 32610042 Free PMC article.

7

Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development.

Conroy S, Kindon N, Kellam B, Stocks MJ. Conroy S, et al. Among authors: kellam b. J Med Chem. 2016 Nov 23;59(22):9981-10005. doi: 10.1021/acs.jmedchem.5b01972. Epub 2016 Aug 1. J Med Chem. 2016. PMID: 27413802 Review.

8

Nucleoside-Based Self-Assembling Drugs for Localized Drug Delivery.

Skilling KJ, Stocks MJ, Kellam B, Ashford M, Bradshaw TD, Burroughs L, Marlow M. Skilling KJ, et al. Among authors: kellam b. ChemMedChem. 2018 Jun 6;13(11):1098-1101. doi: 10.1002/cmdc.201800063. Epub 2018 May 8. ChemMedChem. 2018. PMID: 29570948

9

NanoBiT Complementation to Monitor Agonist-Induced Adenosine A₁ Receptor Internalization.

Soave M, Kellam B, Woolard J, Briddon SJ, Hill SJ. Soave M, et al. Among authors: kellam b. SLAS Discov. 2020 Feb;25(2):186-194. doi: 10.1177/2472555219880475. Epub 2019 Oct 4. SLAS Discov. 2020. PMID: 31583945 Free PMC article.

10

Fluorescently Labeled Morphine Derivatives for Bioimaging Studies.

Lam R, Gondin AB, Canals M, Kellam B, Briddon SJ, Graham B, Scammells PJ. Lam R, et al. Among authors: kellam b. J Med Chem. 2018 Feb 8;61(3):1316-1329. doi: 10.1021/acs.jmedchem.7b01811. Epub 2018 Jan 10. J Med Chem. 2018. PMID: 29291353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results